BACKGROUND: Moxidectin has previously shown limited efficacy (≤ 44.4%) against confirmed macrocyclic lactone (ML)-resistant Dirofilaria immitis strains at 3 µg/kg after single and multiple oral dosages. Three studies were conducted to evaluate higher oral moxidectin doses for efficacy against confirmed ML-resistant D. immitis strains. METHODS: Dogs were inoculated with 50 D. immitis L3 and randomly allocated to treatments. Study 1: 6 groups of dogs (n = 8) were inoculated with JYD-34 (Day - 30) and treated as follows: T01, negative control; T02-T05, moxidectin at 3, 6, 12 or 24 µg/kg, respectively, on Day 0 only; T06, moxidectin at 3 µg/kg on Days 0, 30 and 60. Study 2: 10 groups of dogs (n = 5) were inoculated (Day - 30) with either JYD-34 (T01, T03-05) or ZoeLA (T02, T06-T10) and treated as follows: T01 and T02, negative controls; T03-T05, moxidectin at 24, 40 or 60 µg/kg, respectively, on Days 0, 28 and 56; T06 and T09, moxidectin at 3 or 60 µg/kg on Day 0 only; T07, T08 and T10, moxidectin at 24, 40 or 60 µg/kg, respectively, on Days 0, 28 and 56. Study 3: 5 groups of dogs (n = 5) were inoculated with ZoeMO (Day - 28) and treated as follows: T01, negative control; T02, moxidectin at 3 µg/kg moxidectin on Day 0 only; T03-T05, moxidectin at 24, 40 or 60 µg/kg, respectively, on Days 0, 28 and 56. All dogs were necropsied for adult heartworm recovery ~ 4-5 months post-inoculation. RESULTS: All moxidectin-treated dogs showed significantly lower worm counts than controls. The efficacy of moxidectin administered once at 3 µg/kg was 19% (JYD-34), 44.4% (ZoeLA) and 82.1% (ZoeMO). Increasing both the dose and the number of dosages of moxidectin improved efficacy, with 100% protection obtained using three dosages of moxidectin at either 40 µg/kg (JYD-34, ZoeMO) or 60 µg/kg (ZoeLA). Three dosages of 24 µg/kg were also highly effective, providing ≥ 98.8% efficacy for all three strains. CONCLUSIONS: Increasing both the dose and number of consecutive monthly dosages of moxidectin improved the efficacy against ML-resistant heartworms. Based on these data and other technical considerations, the 24 µg/kg dose was considered the optimal dose for further commercial development.
BACKGROUND:Moxidectin has previously shown limited efficacy (≤ 44.4%) against confirmed macrocyclic lactone (ML)-resistant Dirofilaria immitis strains at 3 µg/kg after single and multiple oral dosages. Three studies were conducted to evaluate higher oral moxidectin doses for efficacy against confirmed ML-resistant D. immitis strains. METHODS:Dogs were inoculated with 50 D. immitis L3 and randomly allocated to treatments. Study 1: 6 groups of dogs (n = 8) were inoculated with JYD-34 (Day - 30) and treated as follows: T01, negative control; T02-T05, moxidectin at 3, 6, 12 or 24 µg/kg, respectively, on Day 0 only; T06, moxidectin at 3 µg/kg on Days 0, 30 and 60. Study 2: 10 groups of dogs (n = 5) were inoculated (Day - 30) with either JYD-34 (T01, T03-05) or ZoeLA (T02, T06-T10) and treated as follows: T01 and T02, negative controls; T03-T05, moxidectin at 24, 40 or 60 µg/kg, respectively, on Days 0, 28 and 56; T06 and T09, moxidectin at 3 or 60 µg/kg on Day 0 only; T07, T08 and T10, moxidectin at 24, 40 or 60 µg/kg, respectively, on Days 0, 28 and 56. Study 3: 5 groups of dogs (n = 5) were inoculated with ZoeMO (Day - 28) and treated as follows: T01, negative control; T02, moxidectin at 3 µg/kg moxidectin on Day 0 only; T03-T05, moxidectin at 24, 40 or 60 µg/kg, respectively, on Days 0, 28 and 56. All dogs were necropsied for adult heartworm recovery ~ 4-5 months post-inoculation. RESULTS: All moxidectin-treated dogs showed significantly lower worm counts than controls. The efficacy of moxidectin administered once at 3 µg/kg was 19% (JYD-34), 44.4% (ZoeLA) and 82.1% (ZoeMO). Increasing both the dose and the number of dosages of moxidectin improved efficacy, with 100% protection obtained using three dosages of moxidectin at either 40 µg/kg (JYD-34, ZoeMO) or 60 µg/kg (ZoeLA). Three dosages of 24 µg/kg were also highly effective, providing ≥ 98.8% efficacy for all three strains. CONCLUSIONS: Increasing both the dose and number of consecutive monthly dosages of moxidectin improved the efficacy against ML-resistant heartworms. Based on these data and other technical considerations, the 24 µg/kg dose was considered the optimal dose for further commercial development.
Authors: Catherine Bourguinat; Alice C Y Lee; Regina Lizundia; Byron L Blagburn; Janice L Liotta; Marc S Kraus; Kathy Keller; Christian Epe; Louis Letourneau; Claudia L Kleinman; Tara Paterson; Elena Carreton Gomez; José Alberto Montoya-Alonso; Hubert Smith; Aron Bhan; Andrew S Peregrine; James Carmichael; Jason Drake; Rudolf Schenker; Ronald Kaminsky; Dwight D Bowman; Timothy G Geary; Roger K Prichard Journal: Vet Parasitol Date: 2015-04-13 Impact factor: 2.738
Authors: Daniel E Snyder; Scott Wiseman; Dwight D Bowman; John W McCall; Craig R Reinemeyer Journal: Vet Parasitol Date: 2011-04-04 Impact factor: 2.738
Authors: Dwight D Bowman; Tom L McTier; Eric L Adams; Sean P Mahabir; Joyce A Login; Tara Bidgood; Debra J Woods Journal: Parasit Vectors Date: 2017-11-09 Impact factor: 3.876
Authors: Tom L McTier; Robert H Six; Aleah Pullins; Sara Chapin; John W McCall; Douglas Rugg; Steven J Maeder; Debra J Woods Journal: Parasit Vectors Date: 2017-11-09 Impact factor: 3.876
Authors: Dwight D Bowman; Cameon M Ohmes; Joseph A Hostetler; Daniel J Keil; Terry L Settje; Samuel D Charles Journal: Parasit Vectors Date: 2017-11-09 Impact factor: 3.876
Authors: Tom L McTier; Kristina Kryda; Martha Wachowski; Sean Mahabir; Deborah Ramsey; Doug Rugg; Mark Mazaleski; Carol Therrien; Eric Adams; T Wolff; Dwight D Bowman Journal: Parasit Vectors Date: 2019-07-26 Impact factor: 3.876
Authors: Byron L Blagburn; Robert G Arther; Allen R Dillon; Jamie M Butler; Joy V Bowles; Cristiano von Simson; Robert Zolynas Journal: Parasit Vectors Date: 2016-04-05 Impact factor: 3.876
Authors: Sandra Noack; John Harrington; Douglas S Carithers; Ronald Kaminsky; Paul M Selzer Journal: Int J Parasitol Drugs Drug Resist Date: 2021-04-27 Impact factor: 4.077
Authors: Kristina Kryda; Susan Holzmer; William R Everett; John W McCall; Sean P Mahabir; Tom L McTier; Steven J Maeder Journal: Parasit Vectors Date: 2020-07-14 Impact factor: 3.876
Authors: Jamie A E Myers; Susan Holzmer; John W McCall; Sean P Mahabir; Tom L McTier; Steven J Maeder; Kristina Kryda Journal: Parasit Vectors Date: 2022-03-11 Impact factor: 3.876